PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 164 filers reported holding PRECIGEN INC in Q3 2020. The put-call ratio across all filers is 1.75 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $248,300 | +23.5% | 174,859 | 0.0% | 0.00% | – |
| Q2 2023 | $201,088 | +8.5% | 174,859 | 0.0% | 0.00% | – |
| Q1 2023 | $185,351 | -30.5% | 174,859 | -0.4% | 0.00% | – |
| Q4 2022 | $266,748 | +1059.8% | 175,492 | +1519.8% | 0.00% | – |
| Q3 2022 | $23,000 | +53.3% | 10,834 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -34.8% | 10,834 | 0.0% | 0.00% | – |
| Q1 2022 | $23,000 | -48.9% | 10,834 | -11.3% | 0.00% | – |
| Q4 2021 | $45,000 | -50.0% | 12,209 | -32.4% | 0.00% | – |
| Q3 2021 | $90,000 | -19.6% | 18,059 | +4.9% | 0.00% | – |
| Q2 2021 | $112,000 | -0.9% | 17,209 | +4.9% | 0.00% | – |
| Q1 2021 | $113,000 | -28.9% | 16,409 | +5.3% | 0.00% | – |
| Q4 2020 | $159,000 | +54.4% | 15,581 | -24.6% | 0.00% | – |
| Q2 2020 | $103,000 | -20.8% | 20,651 | -45.8% | 0.00% | – |
| Q1 2020 | $130,000 | – | 38,136 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |